BRPI1016064A2 - "formulação com compartimentos múltiplos, processo para a preparação da mesma, agentes de transporte ou de vetorização, e de liberação intracelular de agentes terapêuticos, utilização de uma formulação, e composição farmacêutica" - Google Patents

"formulação com compartimentos múltiplos, processo para a preparação da mesma, agentes de transporte ou de vetorização, e de liberação intracelular de agentes terapêuticos, utilização de uma formulação, e composição farmacêutica"

Info

Publication number
BRPI1016064A2
BRPI1016064A2 BRPI1016064A BRPI1016064A BRPI1016064A2 BR PI1016064 A2 BRPI1016064 A2 BR PI1016064A2 BR PI1016064 A BRPI1016064 A BR PI1016064A BR PI1016064 A BRPI1016064 A BR PI1016064A BR PI1016064 A2 BRPI1016064 A2 BR PI1016064A2
Authority
BR
Brazil
Prior art keywords
formulation
agents
carriers
pharmaceutical composition
preparing same
Prior art date
Application number
BRPI1016064A
Other languages
English (en)
Inventor
Camplo Michel
Barthelemy Philippe
Khiati Salim
Original Assignee
Univ Bordeaux Segalen
Univ De La Mediterranee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bordeaux Segalen, Univ De La Mediterranee filed Critical Univ Bordeaux Segalen
Publication of BRPI1016064A2 publication Critical patent/BRPI1016064A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1016064A 2009-05-29 2010-05-28 "formulação com compartimentos múltiplos, processo para a preparação da mesma, agentes de transporte ou de vetorização, e de liberação intracelular de agentes terapêuticos, utilização de uma formulação, e composição farmacêutica" BRPI1016064A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0902607A FR2945946B1 (fr) 2009-05-29 2009-05-29 Formulations a compartiments multiples a base de molecules ou macromolecules amphiphiles fonctionnelles
PCT/FR2010/000401 WO2010136676A1 (fr) 2009-05-29 2010-05-28 Formulations à compartiments multiples à base de molécules ou macromolécules amphiphiles fonctionnelles

Publications (1)

Publication Number Publication Date
BRPI1016064A2 true BRPI1016064A2 (pt) 2019-09-24

Family

ID=41820552

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1016064A BRPI1016064A2 (pt) 2009-05-29 2010-05-28 "formulação com compartimentos múltiplos, processo para a preparação da mesma, agentes de transporte ou de vetorização, e de liberação intracelular de agentes terapêuticos, utilização de uma formulação, e composição farmacêutica"

Country Status (11)

Country Link
US (1) US9050268B2 (pt)
EP (1) EP2435031B1 (pt)
JP (1) JP5913094B2 (pt)
CN (1) CN102458379B (pt)
BR (1) BRPI1016064A2 (pt)
CA (1) CA2763139A1 (pt)
ES (1) ES2556635T3 (pt)
FR (1) FR2945946B1 (pt)
IL (1) IL216623A (pt)
RU (1) RU2011153706A (pt)
WO (1) WO2010136676A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924430B1 (fr) * 2007-11-30 2010-03-19 Univ Bordeaux 2 Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation
MD4307C1 (ro) * 2013-11-28 2015-05-31 Технический университет Молдовы Metodă de stimulare a motilităţii tractului gastro-intestinal
EP3085360A1 (en) 2015-04-20 2016-10-26 Universite De Bordeaux Lipid based nanocarrier compositions loaded with metal nanoparticles and therapeutic agent
CA3033867A1 (en) 2016-08-17 2018-02-22 Solstice Biologics, Ltd. Polynucleotide constructs
US11597744B2 (en) 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use
EP3502684A1 (en) 2017-12-22 2019-06-26 Universite De Bordeaux Method for metal ion detection in aqueous solutions using nucleolipid compounds
FR3078064A1 (fr) 2018-02-22 2019-08-23 Universite de Bordeaux Procede de decontamination d'un milieu liquide aqueux contenant des micropolluants
WO2023135299A1 (en) 2022-01-17 2023-07-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Oligonucleotide solid nucleolipid nanoparticles for tackling antibiotic resistance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041581A (en) 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US6001817A (en) 1998-01-12 1999-12-14 Unitech Pharmaceuticals, Inc. Pharmaceutical composition comprised of cisplatin, and processes for making and using same
US7101575B2 (en) * 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
WO2001032139A2 (en) 1999-11-05 2001-05-10 Seed Capital Investment-2 (Sci-2) B.V. Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained
EP1585504A4 (en) * 2002-11-06 2009-07-15 Azaya Therapeutics Inc Protein stabilized liposomal formulations of pharmaceutical active ingredients
FR2869616B1 (fr) * 2004-04-29 2008-10-24 Univ D Avignon Et Des Pays Du Nouveaux composes amphiphiles, leur procede de preparation et leurs applications notamment a la transfection
US7908160B2 (en) 2006-09-11 2011-03-15 Decision-Zone Inc. System and method for producing audit trails
US7906147B2 (en) * 2006-10-12 2011-03-15 Nanoprobes, Inc. Functional associative coatings for nanoparticles
FR2924430B1 (fr) * 2007-11-30 2010-03-19 Univ Bordeaux 2 Procede de preparation de nanoparticules a base de molecules ou macromolecules amphiphiles fonctionnelles et leur utilisation

Also Published As

Publication number Publication date
JP2012528133A (ja) 2012-11-12
ES2556635T3 (es) 2016-01-19
CN102458379A (zh) 2012-05-16
US20120070505A1 (en) 2012-03-22
EP2435031A1 (fr) 2012-04-04
FR2945946B1 (fr) 2011-08-26
CN102458379B (zh) 2014-05-14
WO2010136676A1 (fr) 2010-12-02
IL216623A (en) 2015-03-31
IL216623A0 (en) 2012-02-29
RU2011153706A (ru) 2013-07-10
JP5913094B2 (ja) 2016-04-27
FR2945946A1 (fr) 2010-12-03
CA2763139A1 (fr) 2010-12-02
EP2435031B1 (fr) 2015-09-16
US9050268B2 (en) 2015-06-09

Similar Documents

Publication Publication Date Title
BRPI1016064A2 (pt) "formulação com compartimentos múltiplos, processo para a preparação da mesma, agentes de transporte ou de vetorização, e de liberação intracelular de agentes terapêuticos, utilização de uma formulação, e composição farmacêutica"
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
IL215065A (en) Proline derivatives, their preparation process, their pharmaceutical compositions and their uses in drug preparation
IL212573A (en) Aryl Methyl Benzokinazulinone Compounds
IL212435A (en) Isoindulin compounds, their pharmaceutical compositions and their use in the preparation of drugs
IL219309A (en) History of glycoside, including pharmaceutical preparations and their use in the preparation of diabetes medications
BR112015000150A2 (pt) composições farmacêuticas dissuasoras de abuso de liberação controlada
IL206952A (en) History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
BRPI0817075A2 (pt) núcleos de fármaco para liberação prolongada de agentes terapêuticos
EP2659883A4 (en) MICROCAPSE PREPARATION OF ALGINATCHITOSANACYL DERIVATIVES, MANUFACTURE AND APPLICATION
UY31918A (es) Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento
DOP2011000218A (es) Derivados de sulfonamida
IL216741A (en) History of imidazolidine-2-van 1,3-imaging modalities as 17-cyp inhibitors, pharmaceutical preparations containing them, and their use in the preparation of drugs for the treatment of diseases
CL2007001427A1 (es) Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po
BRPI0816991A2 (pt) Formulação, processo para preparar a mesma, e, usos de uma composição antimicrobiana e de uma formulação
BR122017015098B8 (pt) formulações farmacêuticas de liberação imediata que contêm hidrato de propileno glicol de dapagliflozina
BRPI0914371A2 (pt) "composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"
BRPI0816320A2 (pt) Composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto de combinação, e, processos para a preparação deu um composto, de uma formulação farmacêutica, e de um produto de combinação
BRPI0819957A2 (pt) "composição farmacêutica estável e sustentada de hidrocloreto de bupropiona e processo para a preparação da mesma"
BRPI0814666A2 (pt) composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida
BR112014022214A2 (pt) fenólicos antibacterianos
BRPI0717766A2 (pt) Processo para preparar composições contendo polifenol, composição, produto alimentício, medicamento, e, produto cosmético
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
IL218277B (en) Tetracycline compounds, pharmaceutical preparations containing them and their use for the preparation of medicines for the treatment and prevention of infection

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: UNIVERSITE BORDEAUX SEGALEN (FR) ; UNIVERSITE D`AI

Owner name: UNIVERSITE BORDEAUX SEGALEN (FR) ; UNIVERSITE D`AIX-MARSEILLE (FR)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.